You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
溢多利(300381.SZ):子公司通過韓國MFDS現場檢查 涉及醋酸潑尼鬆龍產品
格隆匯 05-07 17:56

格隆匯5月7日丨溢多利(300381.SZ)公佈,公司全資子公司河南利華製藥有限公司(“利華製藥”)於2019年9月3日至5日接受了韓國食品藥品安全部(“MFDS”)官方的《藥品生產質量管理規範》(GMP)現場檢查,此次檢查涉及的產品為利華製藥的醋酸潑尼鬆龍產品。

近日,利華製藥收韓國MFDS簽發的《醫藥品海外供應商現場審計結果通知》,現場檢查結果利華製藥GMP運營狀態符合韓國有關的原料醫藥品生產及質量管理標準利華製藥原料藥醋酸潑尼鬆龍通過韓國MFDSGMP現場檢查。

利華製藥本次順利通過韓國MFDS現場檢查,體現了公司生產質量及安全管理水平始終保持與國際標準接軌,有利於公司加強與韓國客户的合作,提高公司產品的市場競爭力,對公司進一步開拓韓國市場和其他國際市場有着積極的作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account